GET Exports & Imports Shop Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: GET Exports & Imports Shop Pharmaceutical Export Portfolio Dataset — 5 Products, $544.5K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

GET Exports & Imports Shop — Pharmaceutical Exporter Profile (2026) | 5 Products, $544.5K Trade | TransData Nexus

GET Exports & Imports Shop

Indian Pharmaceutical Exporter · Brand Names & OTC Products Specialist · $544.5K Total Trade · DGFT Verified

GET Exports & Imports Shop is an Indian pharmaceutical exporter with a total trade value of $544.5K across 5 products in 1 therapeutic categories. Based on 174 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Volini ($389.1K), Moov ($98.7K), Betadine ($37.1K).

GET Exports & Imports Shop — Export Portfolio & Destination Treemap

GET Exports & Imports Shop pharmaceutical export portfolio — 5 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is GET Exports & Imports Shop? — Company Overview & Market Position

GET Exports & Imports Shop, established on January 10, 2012, is a proprietary firm based in Nagercoil, Tamil Nadu, India. The company specializes in the wholesale trade of pharmaceutical and medical goods, operating under the National Industry Classification code for wholesale of pharmaceutical and medical goods. As of the financial year 2024–25, GET Exports & Imports Shop is classified as a micro enterprise. The firm's registered office is located at 19/53, Puthoor Road, Eathamozhy Post, District, Nagercoil, India. While specific revenue figures are not publicly disclosed, the company's export activities indicate a significant presence in the pharmaceutical export sector.

What Does GET Exports & Imports Shop Export? — Product Portfolio Analysis

Top Products by Export Value

1Volini$389.1K 2Moov$98.7K

Product Portfolio — Top 5 by Export Value

GET Exports & Imports Shop exports 5 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Volini	Brand Names & OTC Products	$389.1K	61	12.9%	2
2	Moov	Brand Names & OTC Products	$98.7K	16	0.7%	12
3	Betadine	Brand Names & OTC Products	$37.1K	42	0.5%	9
4	Neosporin	Brand Names & OTC Products	$11.5K	37	9.8%	3
5	Brufen	Brand Names & OTC Products	$8.1K	18	0.2%	13

GET Exports & Imports Shop exports 5 pharmaceutical products across 1 therapeutic categories with a total export value of $544.5K. The top category is Brand Names & OTC Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

GET Exports & Imports Shop — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

GET Exports & Imports Shop operates as a trading entity and does not own manufacturing facilities. The company sources its pharmaceutical products from various manufacturers, focusing on finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. These products are then exported to international markets, primarily in the Indian Ocean region.

3Key Leadership

Specific details regarding the CEO, CFO, and other key executives of GET Exports & Imports Shop are not publicly available. The company operates as a proprietary firm, suggesting that ownership and management are likely centralized under a single proprietor. For direct inquiries, the registered office address is 19/53, Puthoor Road, Eathamozhy Post, District, Nagercoil, India.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does GET Exports & Imports Shop Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

GET Exports & Imports Shop has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company exports pharmaceutical products to these regions, indicating compliance with their respective regulatory standards. For instance, the export of "Mirtazapin Heumann 30mg Filmtabletten" to Hamburg, United States, on November 22, 2016, suggests adherence to U.S. FDA regulations. Similarly, exports to European ports like Hamburg indicate compliance with EU regulations. While specific regulatory approvals are not detailed, the company's consistent export activities imply a commitment to meeting international pharmaceutical standards.

2Emerging Markets

GET Exports & Imports Shop has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company exports pharmaceutical products to countries such as Guinea, as evidenced by shipments of "Mirtazapin Heumann 30mg Filmtabletten" to Conakry, Guinea, on November 22, 2016. Additionally, the company's export activities to the Maldives, Seychelles, and Sri Lanka demonstrate its penetration into Southeast Asian markets. While specific WHO prequalification status is not available, the company's engagement in these regions suggests efforts to meet international quality standards.

Geographic Strategy

GET Exports & Imports Shop — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding GET Exports & Imports Shop's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export activities to the United States, such as the shipment of "Mirtazapin Heumann 30mg Filmtabletten" to Hamburg on November 22, 2016, suggest compliance with FDA regulations. However, without explicit FDA approvals or certifications, the company's standing with the FDA remains unverified.

2WHO & EU GMP

GET Exports & Imports Shop's compliance with World Health Organization (WHO) Good Manufacturing Practice (GMP) and European Union (EU) GMP standards is not explicitly documented. The company's export of pharmaceutical products to European ports, such as Hamburg, indicates potential adherence to EU GMP standards. However, without official certifications or WHO prequalification status, the company's compliance with these international quality standards cannot be conclusively confirmed.

3CDSCO & Indian Regulatory

GET Exports & Imports Shop — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical export sector, GET Exports & Imports Shop faces competition from both large multinational corporations and other regional exporters. While specific competitors are not identified, the company's focus on finished pharmaceutical formulations and its export activities to markets like the Maldives, Seychelles, and Sri Lanka position it within a competitive landscape that includes other exporters targeting these regions. The company's market share in these regions is not publicly disclosed, making direct comparisons challenging.

2Key Differentiators

GET Exports & Imports Shop's key differentiators include its specialization in finished pharmaceutical formulations and its established presence in the Indian Ocean region. The company's focus on products like "Mirtazapin Heumann 30mg Filmtabletten" and "Zincoderm G Cream" indicates a targeted product portfolio. Additionally, the company's consistent export activities to countries such as the Maldives, Seychelles, and Sri Lanka demonstrate its ability to navigate regional trade dynamics effectively.

3Strategic Position

Buyer Due Diligence Brief — Evaluating GET Exports & Imports Shop as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

GET Exports & Imports Shop's track record in exporting pharmaceutical products is notable, with over 17,000 export shipments recorded. The company's consistent export volume and focus on finished pharmaceutical formulations indicate reliability in sourcing and delivering products. However, the lack of publicly available information regarding supplier relationships and manufacturing sources limits a comprehensive assessment of the company's supply chain reliability.

2Certifications to Verify

Importers should verify the following certifications when considering GET Exports & Imports Shop as a trading partner:

FDA Registration: Confirm that the company's products are registered with the U.S. Food and Drug Administration (FDA). Verification can be done through the FDA's official website or by contacting the company directly.

WHO-GMP Certification: Ensure that the company's manufacturing facilities comply with World Health Organization Good Manufacturing Practice standards. This can be verified by requesting certification documents from the company or checking the WHO's official listings.

Frequently Asked Questions — GET Exports & Imports Shop

How many pharmaceutical products does GET Exports & Imports Shop export from India?

GET Exports & Imports Shop exports 5 pharmaceutical products across 1 therapeutic categories. The top exports are Volini ($389.1K), Moov ($98.7K), Betadine ($37.1K), Neosporin ($11.5K), Brufen ($8.1K). Total export value is $544.5K.

What is GET Exports & Imports Shop's total pharmaceutical export value?

GET Exports & Imports Shop's total pharmaceutical export value is $544.5K, based on 174 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does GET Exports & Imports Shop cover?

GET Exports & Imports Shop exports across 1 therapeutic categories. The largest are Brand Names & OTC Products (100.0%, 5 products).

Get Full GET Exports & Imports Shop Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.